About urinary incontinence
Urinary incontinence is any involuntary urine leakage. It may occur as a result of an abnormal function of the lower urinary tract, overactive bladder, or other illnesses. It is estimated that about 50 percent of women suffer from urinary incontinence at some point in their lives. In men, the prevalence is 5 percent, and most cases are related to prostate diseases. The severity depends on the psychological, physical, and social well-being of the affected individuals.
Analysts forecast the urinary incontinence products market in Europe to grow at a CAGR of 6.38% over the period 2014-2019.
Read more details at: http://www.bigmarketresearch.com/urinary-incontinence-products-in-europe-2015-2019-market
This report covers the present scenario and growth prospects of the urinary incontinence products market in Europe for the period 2015-2019. To calculate the market size, the report considers the revenue generated from sales of different types of urinary incontinence treatment products.
Urinary Incontinence Products Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. It also covers the landscape of the urinary incontinence products market in Europe and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key countries
• Germany
• UK
Key vendors
• American Medical Systems
• Attends Healthcare Group
• B.Braun Melsungen
• C. R. Bard
• Coloplast
• Kimberly-Clark
• Paul Hartmann
• Svenska Cellulosa Aktiebolaget
Other prominent vendor
• Boston Scientific
• ConvaTec
• Dynarex
• Ethicon (Johnson & Johnson)
• Hunter Urology
• Medline Industries
• Ontex International
• P&G
• Uroplasty
Market driver
• Increasing in aging population
• For a full, detailed list, view our report
Market challenge
• Economic burden of UUI
• For a full, detailed list, view our...